Evolv Technologies Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Net Loss per Share

Net Loss per Share

3 Months Ended

Mar. 31, 2023

Basic and diluted net loss per share attributable to common stockholders was calculated as follows (in thousands, except share and per share amounts):


	Three Months Ended March 31,
	2023		2022
Numerator:







Net income (loss) attributable to common stockholders – basic and diluted	$	(28,609)	$	(13,801)

Denominator:











Weighted average common shares outstanding - basic and diluted	146,433,378		142,878,406
Net loss per share attributable to common stockholders – basic and diluted	$	(0.20)	$	(0.10)

The following potentially dilutive outstanding securities were excluded from the computation of diluted net loss per share attributable to common stockholders because their effect would have been anti-dilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period:


	Three Months Ended March 31,
	2023	2022
Options issued and outstanding	23,136,658	21,964,309
Public Warrants to purchase common stock	14,324,994	14,324,993



Warrants to purchase common stock (Finback)**	1,590,984	2,421,200
Unvested restricted stock units	12,395,533	6,251,002
Unvested performance stock units	414,500	934,000
Earn-out shares*	15,000,000	15,000,000
Contingently issuable common stock*	1,897,500	1,897,500

	68,760,169	62,793,004

*Issuance of Earn-out shares and Contingently issuable common stock are contingent upon the satisfaction of certain conditions, which were not satisfied by the end of the period

**Includes 79,677 vested warrants and 1,511,307 unvested warrants as of March 31, 2023